个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Lu, S.[1] * ; Wang, Q.[2] ; Zhang, G.[3] ; Dong, X.[4] ; Yang, C-T.[5] ; Song, Y.[6] ; Chang, G-C.[7] ; Lu, Y.[8] ; Pan, H.[9] ; Chiu, C-H.[10] ; Wang, Z.[11] ; Feng, J.[12] ; Zhou, J.[13] ; Xu, X.[14] ; Guo, R.[15] ; Chen, J.[16,17] ; Yang, H.[18] ; Chen, Y.[19] ; Yu, Z.[20] ; Shiah, H-S.[21] ;
单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Med Oncol, Shanghai, Peoples R China [2]Zhengzhou Univ, Henan Canc Hosp, Dept Internal Med, Zhengzhou, Peoples R China [3]Zhengzhou Univ, Affiliated Hosp 1, Dept Respirat, Zhengzhou, Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China [5]Linkou Chang Gung Memorial Hosp, Dept Thorac Med, Taoyuan, Taiwan [6]Gen Hosp PLA Eastern Theater Command, Dept Respirat, Nanjing, Jiangsu, Peoples R China [7]Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan [8]Sichuan Univ, Dept Thorac Oncol, West China Hosp, Chengdu, Peoples R China [9]Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Oncol, Hangzhou, Peoples R China [10]Taipei Vet Gen Hosp, Dept Chest Med, Div Thorac Oncol, Taipei, Taiwan [11]Shandong Canc Hosp, Dept Oncol, Shandong, Peoples R China [12]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Dept Internal Med,Shandong Canc Hosp, Nanjing, Peoples R China [13]Zhejiang Univ, Affiliated Hosp 1, Dept Resp Med, Sch Med, Hangzhou, Peoples R China [14]Yangzhou Univ, Affiliated Hosp, Dept Respirat, Northern Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China [15]Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Jiangsu Prov Hosp, Nanjing, Peoples R China [16]Hunan Canc Hosp, Dept Med Oncol Chest, Changsha, Peoples R China [17]Cent South Univ, Sch Med, Affiliated Canc Hosp Xiangya, Changsha, Peoples R China [18]Taizhou Hosp Zhejiang Prov, Dept Radiotherapy, Taizhou, Peoples R China [19]Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Oncol, Tongji Hosp, Wuhan, Peoples R China [20]Qingdao Univ, Affiliated Hosp, Dept Oncol, Qingdao, Peoples R China [21]Taipei Med Univ Hosp, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan
出处：
DOI： 10.1016/j.annonc.2021.08.1813
ISSN：
基金：
Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2019]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者：
第一作者单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Med Oncol, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Lu S.,Wang Q.,Zhang G.,et al.Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)[J].ANNALS OF ONCOLOGY.2021,32:S962-S962.doi:10.1016/j.annonc.2021.08.1813.
APA：
Lu, S.,Wang, Q.,Zhang, G.,Dong, X.,Yang, C-T....&Shiah, H-S..(2021).Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).ANNALS OF ONCOLOGY,32,
MLA：
Lu, S.,et al."Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)".ANNALS OF ONCOLOGY 32.(2021):S962-S962

资源点击量：434 今日访问量：0 总访问量：419 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）